Patients whose atrial fibrillation lasts longer than seven days and who do not respond well to drug therapy are now eligible ...

The US Food and Drug Administration (FDA) has approved Boston Scientific’s expanded instructions for use (IFU) labelling of ...

Marlborough: Boston Scientific Corporation has announced that the company has received approval from the U.S. Food and Drug ...

MedTech Boston Scientific expands Farapulse’s reach in afib with new FDA approval By Conor Hale Jul 7, 2025 11:58am Boston Scientific FDA pulsed field ablation atrial fibrillation ...

Boston Scientific receives US FDA approval for expanded labelling of Farapulse PFA System: Marlborough, Massachusetts Tuesday, July 8, 2025, 11:00 Hrs [IST] Boston Scientific Corp ...

Boston Scientific’s Farapulse Pulsed Field Ablation System is now approved for treating persistent atrial fibrillation, following 12-month data from the ADVANTAGE AF trial showing strong safety, high ...

Boston Scientific announced the FDA approval of expanded labeling for its pulsed field ablation system which now includes ...

The benefit seems durable, but one expert says patients should be aware there’s “some risk of stroke” during the procedure.

For patients with atrial fibrillation, catheter ablation reduces the risks for ischemic stroke at more than 30 days, ...

Bayer has decided to discontinue a phase 3 trial of its oral Factor XIa inhibitor asundexian in patients with atrial fibrillation (AF), after an interim analysis concluded the novel anticoagulant ...

Boston Scientific (NYSE:BSX) gains FDA nod for expanded use of Farapulse System in treating persistent atrial fibrillation. Read more here.